What People Think
9% For, 91% Against
Take Action
| Vote on this Bill | |
![]() ![]() |
For |
![]() ![]() |
Against |
| Speak Out | |
![]() ![]() |
Comment on this Bill |
![]() ![]() |
Alert Your Friends and Colleagues |
![]() ![]() |
Write Your Representative in Congress |
| Save & Share | |
| del.icio.us | |
| Digg | |
| Yahoo! | |
H.R. 2823, The Fair Balance Prescription Drug Advertisement Act of 2007
H.R. 2823 would amend the Internal Revenue Code of 1986 to deny any deduction for direct-to-consumer advertisements of prescription drugs that fail to provide certain information or to present information in a balanced manner, it would amend the Federal Food, Drug, and Cosmetic Act to require reports regarding such advertisements, and it would amend such Code to deny any deduction for direct-to-consumer advertisements of qualified prescription drugs for a two-year period.
()
Learn More
Trackback URL: http://www.washingtonwatch.com/bills/trackback/110_HR_2823.html
RSS Feeds for This Bill
Keep yourself updated on user contributions and debates about this bill! (Learn more about RSS.)










Visitor Comments
There are currently no comments for this bill.